131 related articles for article (PubMed ID: 35634790)
1. Symptom-based remote assessment in post-treatment head and neck cancer surveillance: A prospective national study.
Zhang H; Hardman JC; Tikka T; Nankivell P; Mehanna H; Paleri V;
Clin Otolaryngol; 2022 Sep; 47(5):561-567. PubMed ID: 35634790
[TBL] [Abstract][Full Text] [Related]
2. Remote triage incorporating symptom-based risk stratification for suspected head and neck cancer referrals: A prospective population-based study.
Hardman JC; Tikka T; Paleri V;
Cancer; 2021 Nov; 127(22):4177-4189. PubMed ID: 34411287
[TBL] [Abstract][Full Text] [Related]
3. Post-Treatment Head and Neck Cancer Care: National Audit and Analysis of Current Practice in the United Kingdom.
INTEGRATE (The UK ENT Trainee Research Network)
Clin Otolaryngol; 2021 Jan; 46(1):284-294. PubMed ID: 32734679
[TBL] [Abstract][Full Text] [Related]
4. Follow-up arrangements in head and neck cancer clinics during the COVID-19 pandemic: results from two tertiary UK head and neck cancer centres.
Kanatas A; Coffey D; Spellman J; Twigg J; Lowe D; Rogers SN
Ann R Coll Surg Engl; 2023 Aug; 105(S2):S60-S68. PubMed ID: 34941427
[TBL] [Abstract][Full Text] [Related]
5. Remote triaging of urgent suspected head and neck cancer referrals: our experience during the first wave of the COVID-19 pandemic.
Kaddour H; Jama GM; Stagnell S; Kaddour S; Guner K; Kumar G
Eur Arch Otorhinolaryngol; 2022 Feb; 279(2):1111-1115. PubMed ID: 34661717
[TBL] [Abstract][Full Text] [Related]
6. Rapid implementation of an evidence-based remote triaging system for assessment of suspected referrals and patients with head and neck cancer on follow-up after treatment during the COVID-19 pandemic: Model for international collaboration.
Paleri V; Hardman J; Tikka T; Bradley P; Pracy P; Kerawala C
Head Neck; 2020 Jul; 42(7):1674-1680. PubMed ID: 32374942
[TBL] [Abstract][Full Text] [Related]
7. Coronavirus disease 2019 pandemic telephone two-week-wait referrals in head and neck cancer - how safe were they?
Lau KL; Wilson M; Oozeer N; Cocks H
J Laryngol Otol; 2024 Mar; 138(3):321-324. PubMed ID: 37403606
[TBL] [Abstract][Full Text] [Related]
8. The follow-up of patients with head and neck cancer: an analysis of 1,039 patients.
Kothari P; Trinidade A; Hewitt RJD; Singh A; O'Flynn P
Eur Arch Otorhinolaryngol; 2011 Aug; 268(8):1191-1200. PubMed ID: 21193920
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of a Telephone-Based Questionnaire for Follow-up of Patients Who Have Completed Curative-Intent Treatment for Oral Cancers.
Malik A; Nair S; Sonawane K; Lamba K; Ghosh-Laskar S; Prabhash K; Pai P; Chaukar D; Nair D; Chaturvedi P
JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1102-1108. PubMed ID: 32880626
[TBL] [Abstract][Full Text] [Related]
10. Telephone triage of suspected head and neck cancer patients during the coronavirus disease 2019 pandemic using the Head and Neck Cancer Risk Calculator version 2.
Banerjee S; Voliotidis D; Parvin L; Rama SPK
J Laryngol Otol; 2021 Mar; 135(3):241-245. PubMed ID: 33648611
[TBL] [Abstract][Full Text] [Related]
11. Telephone consultation for two-week-wait ENT and head and neck cancer referrals: initial evaluation including patient satisfaction.
Rovira A; Brar S; Munroe-Gray T; Ofo E; Rodriguez C; Kim D
J Laryngol Otol; 2022 Jul; 136(7):615-621. PubMed ID: 34698005
[TBL] [Abstract][Full Text] [Related]
12. Is the early identification and referral of suspected head and neck cancers by community pharmacists feasible? A qualitative interview study exploring the views of patients in North East England.
Bissett SM; Sturrock A; Carrozzo M; Lish R; Howe D; Mountain S; Nugent M; O'Hara J; Todd A; Wilkes S; Preshaw PM
Health Expect; 2023 Oct; 26(5):2089-2097. PubMed ID: 37458410
[TBL] [Abstract][Full Text] [Related]
13. Challenges in diagnosing head and neck cancer in primary health care.
Nieminen M; Aro K; Mäkitie A; Harlin V; Kainulainen S; Jouhi L; Atula T
Ann Med; 2021 Dec; 53(1):26-33. PubMed ID: 32746635
[TBL] [Abstract][Full Text] [Related]
14. Deprivation in relation to urgent suspicion of head and neck cancer referrals in Glasgow.
Zeitler M; Fingland P; Tikka T; Douglas CM; Montgomery J
Clin Otolaryngol; 2018 Jun; 43(3):861-867. PubMed ID: 29380938
[TBL] [Abstract][Full Text] [Related]
15. Head and neck cancer risk calculator (HaNC-RC)-V.2. Adjustments and addition of symptoms and social history factors.
Tikka T; Kavanagh K; Lowit A; Jiafeng P; Burns H; Nixon IJ; Paleri V; MacKenzie K
Clin Otolaryngol; 2020 May; 45(3):380-388. PubMed ID: 31985180
[TBL] [Abstract][Full Text] [Related]
16. Impact of COVID-19 pandemic on head-neck cancer referral and treatment pathway in North East London.
Zubair A; Jamshaid S; Scholfield DW; Hariri AA; Ahmed J; Ghufoor K; Ali S
Ann R Coll Surg Engl; 2023 Aug; 105(S2):S28-S34. PubMed ID: 35446702
[TBL] [Abstract][Full Text] [Related]
17. Effect of coronavirus disease 2019 on recurrences and follow up of head and neck squamous cell carcinoma.
Kytö E; Haapio E; Kinnunen I; Irjala H
J Laryngol Otol; 2021 Apr; 135(4):344-347. PubMed ID: 33752762
[TBL] [Abstract][Full Text] [Related]
18. A longitudinal study of follow-up activities after curative treatment for head and neck cancer.
Pagh A; Grau C; Overgaard J
Acta Oncol; 2015 May; 54(5):813-9. PubMed ID: 25907822
[TBL] [Abstract][Full Text] [Related]
19. Recurrent head and neck cancer: United Kingdom National Multidisciplinary Guidelines.
Mehanna H; Kong A; Ahmed SK
J Laryngol Otol; 2016 May; 130(S2):S181-S190. PubMed ID: 27841130
[TBL] [Abstract][Full Text] [Related]
20. Head and neck cancer: A 6-year retrospective analysis and review of three common triaging systems.
Siddiqui Z; Hamid M; Caton N; Cheang PP
Clin Otolaryngol; 2023 Jul; 48(4):630-637. PubMed ID: 36977627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
